[
  {
    "ts": null,
    "headline": "Gilead Sciences to Present at Upcoming Investor Engagements",
    "summary": "FOSTER CITY, Calif., November 08, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:",
    "url": "https://finnhub.io/api/news?id=62a857b92744f519c38290c01d0a98c62266b36a3626de5ad2b155aafccea3ec",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731099900,
      "headline": "Gilead Sciences to Present at Upcoming Investor Engagements",
      "id": 131233661,
      "image": "https://s.yimg.com/ny/api/res/1.2/oTBexXf7JD7DLP_2IfKKBw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD00MDA-/https://media.zenfs.com/en/business-wire.com/c828f14d74654e03d94dc38b78a5d232",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "FOSTER CITY, Calif., November 08, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conferences:",
      "url": "https://finnhub.io/api/news?id=62a857b92744f519c38290c01d0a98c62266b36a3626de5ad2b155aafccea3ec"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences: Finally Some Real Momentum",
    "summary": "Financial writer discusses Gilead Sciences, Inc. stock downturn and recovery, cautioning against potential future volatility. Click for my GILD stock update.",
    "url": "https://finnhub.io/api/news?id=2a22d84507ec794b6768e300487a282def6dd6db04cae8140d975ecc70b4f320",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731084265,
      "headline": "Gilead Sciences: Finally Some Real Momentum",
      "id": 131231814,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1189813806/image_1189813806.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Financial writer discusses Gilead Sciences, Inc. stock downturn and recovery, cautioning against potential future volatility. Click for my GILD stock update.",
      "url": "https://finnhub.io/api/news?id=2a22d84507ec794b6768e300487a282def6dd6db04cae8140d975ecc70b4f320"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags",
    "summary": "Gilead Sciences ( NASDAQ:GILD ) Third Quarter 2024 Results Key Financial Results Revenue: US$7.55b (up 7.0% from 3Q...",
    "url": "https://finnhub.io/api/news?id=7ccf23f317b4b292bfad6df955d2a071467ed01dd9f4f55b4e55351800ccd587",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731070667,
      "headline": "Gilead Sciences Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags",
      "id": 131225045,
      "image": "https://media.zenfs.com/en/simply_wall_st__316/78a8c60a6283aea0450523395306d38c",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Gilead Sciences ( NASDAQ:GILD ) Third Quarter 2024 Results Key Financial Results Revenue: US$7.55b (up 7.0% from 3Q...",
      "url": "https://finnhub.io/api/news?id=7ccf23f317b4b292bfad6df955d2a071467ed01dd9f4f55b4e55351800ccd587"
    }
  },
  {
    "ts": null,
    "headline": "Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon",
    "summary": "Aurinia Pharmaceuticals Inc. had a solid Q3 and announced cost cuts, sparking rumors of potential acquisition and continued profitability. Read more here.",
    "url": "https://finnhub.io/api/news?id=016f0b8169860bf8a4ce466f1bbcc11b423938da5516b43d04ad6b265003f853",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731068131,
      "headline": "Aurinia Pharmaceuticals: A Potential Buyout Looms On The Horizon",
      "id": 131223615,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/155151969/image_155151969.jpg?io=getty-c-w1536",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Aurinia Pharmaceuticals Inc. had a solid Q3 and announced cost cuts, sparking rumors of potential acquisition and continued profitability. Read more here.",
      "url": "https://finnhub.io/api/news?id=016f0b8169860bf8a4ce466f1bbcc11b423938da5516b43d04ad6b265003f853"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. - Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts toward Ending the Epidemic",
    "summary": "FOSTER CITY - Gilead Sciences, Inc. today announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection , taking place from November...",
    "url": "https://finnhub.io/api/news?id=404b33f156418460c2d02481c07d66d82323a5c78fe040e4c200ba63b7a5a4c4",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1731048464,
      "headline": "Gilead Sciences, Inc. - Late-Breaking Clinical Data and Real-World Evidence Presented at HIV Glasgow as Gilead Extends Leadership Efforts toward Ending the Epidemic",
      "id": 131212045,
      "image": "",
      "related": "GILD",
      "source": "Finnhub",
      "summary": "FOSTER CITY - Gilead Sciences, Inc. today announced the upcoming presentation of HIV research findings at the International Congress on Drug Therapy in HIV Infection , taking place from November...",
      "url": "https://finnhub.io/api/news?id=404b33f156418460c2d02481c07d66d82323a5c78fe040e4c200ba63b7a5a4c4"
    }
  }
]